BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 6436431)

  • 1. Identification of the Raji cell membrane-derived C1q inhibitor as a receptor for human C1q. Purification and immunochemical characterization.
    Ghebrehiwet B; Silvestri L; McDevitt C
    J Exp Med; 1984 Nov; 160(5):1375-89. PubMed ID: 6436431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C1q-binding cell membrane proteins cC1q-R and gC1q-R are released from activated cells: subcellular distribution and immunochemical characterization.
    Peterson KL; Zhang W; Lu PD; Keilbaugh SA; Peerschke EI; Ghebrehiwet B
    Clin Immunol Immunopathol; 1997 Jul; 84(1):17-26. PubMed ID: 9191880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and characterization of a murine monoclonal IgM antibody to human C1q receptor (C1qR).
    Ghebrehiwet B
    J Immunol; 1986 Jul; 137(2):618-24. PubMed ID: 3487576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short amino acid sequences derived from C1q receptor (C1q-R) show homology with the alpha chains of fibronectin and vitronectin receptors and collagen type IV.
    Ghebrehiwet B; Peerschke EI; Hong Y; Munoz P; Gorevic PD
    J Leukoc Biol; 1992 Jun; 51(6):546-56. PubMed ID: 1377218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation, cDNA cloning, and overexpression of a 33-kD cell surface glycoprotein that binds to the globular "heads" of C1q.
    Ghebrehiwet B; Lim BL; Peerschke EI; Willis AC; Reid KB
    J Exp Med; 1994 Jun; 179(6):1809-21. PubMed ID: 8195709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible biotinylation of C1q with a cleavable biotinyl derivative. Application in C1q receptor (C1qR) purification.
    Ghebrehiwet B; Bossone S; Erdei A; Reid KB
    J Immunol Methods; 1988 Jun; 110(2):251-60. PubMed ID: 3259972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and partial characterization of human platelet C1q binding sites.
    Peerschke EI; Ghebrehiwet B
    J Immunol; 1988 Nov; 141(10):3505-11. PubMed ID: 3183380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the human C1q receptor.
    Erdei A; Reid KB
    Behring Inst Mitt; 1989 Jul; (84):216-9. PubMed ID: 2679534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of C1q-binding material released from the membranes of Raji and U937 cells by limited proteolysis with trypsin.
    Erdei A; Reid KB
    Biochem J; 1988 Oct; 255(2):493-9. PubMed ID: 3144267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functions associated with the C1q receptor.
    Ghebrehiwet B
    Behring Inst Mitt; 1989 Jul; (84):204-15. PubMed ID: 2679533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The C1q receptor.
    Erdei A; Reid KB
    Mol Immunol; 1988 Nov; 25(11):1067-73. PubMed ID: 3265474
    [No Abstract]   [Full Text] [Related]  

  • 12. C1q receptor.
    Ghebrehiwet B
    Methods Enzymol; 1987; 150():558-78. PubMed ID: 3123878
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemical and hydrodynamic characterization of the human leucocyte receptor for complement subcomponent C1q.
    Malhotra R; Sim RB
    Biochem J; 1989 Sep; 262(2):625-31. PubMed ID: 2803272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of C1q with its receptor on cultured cell lines induces an anti-proliferative response.
    Ghebrehiwet B; Habicht GS; Beck G
    Clin Immunol Immunopathol; 1990 Jan; 54(1):148-60. PubMed ID: 2293904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the binding of purified human C1q to heart mitochondrial membranes.
    Storrs SB; Kolb WP; Pinckard RN; Olson MS
    J Biol Chem; 1981 Nov; 256(21):10924-9. PubMed ID: 6974732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of the function of the first component of complement by human C1q receptor.
    van den Berg RH; Faber-Krol M; van Es LA; Daha MR
    Eur J Immunol; 1995 Aug; 25(8):2206-10. PubMed ID: 7664783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of C1q receptor expression on human phagocytic cells: effects of PDBu and fMLP.
    Bobak DA; Frank MM; Tenner AJ
    J Immunol; 1986 Jun; 136(12):4604-10. PubMed ID: 3486907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-mediated binding of C1q on pulmonary endothelial cells.
    Zhang SC; Schultz DR; Ryan US
    Tissue Cell; 1986; 18(1):13-8. PubMed ID: 3485838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of complement activation after coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo.
    Rossen RD; Michael LH; Kagiyama A; Savage HE; Hanson G; Reisberg MA; Moake JN; Kim SH; Self D; Weakley S
    Circ Res; 1988 Mar; 62(3):572-84. PubMed ID: 3257722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human T cells express specific binding sites for C1q. Role in T cell activation and proliferation.
    Chen A; Gaddipati S; Hong Y; Volkman DJ; Peerschke EI; Ghebrehiwet B
    J Immunol; 1994 Aug; 153(4):1430-40. PubMed ID: 8046223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.